Complementary and alternative medicine for the allergist-immunologist: Where do I start?

Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 200...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2009-02, Vol.123 (2), p.309-316.e4
Hauptverfasser: Engler, Renata J.M., MD, FAAAAI, FACAAI, With, Catherine M., JD, LLM, LLM, Gregory, Philip J., PharmD, Jellin, Jeff M., PharmD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 316.e4
container_issue 2
container_start_page 309
container_title Journal of allergy and clinical immunology
container_volume 123
creator Engler, Renata J.M., MD, FAAAAI, FACAAI
With, Catherine M., JD, LLM, LLM
Gregory, Philip J., PharmD
Jellin, Jeff M., PharmD
description Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.
doi_str_mv 10.1016/j.jaci.2009.01.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1504810623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674909000049</els_id><sourcerecordid>3239287941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</originalsourceid><addsrcrecordid>eNp9kU-LFDEQxYMo7rj6BTxIQDx2W5X-GxFFhl1dWPCgoreQSardtN2dMcks7Lc3zQwuePAUinqvUvV7jD1HKBGwfT2WozauFACyBCwB8AHbIMiuaHvRPGSb3MCi7Wp5xp7EOEKuq14-ZmcoBVRtU2_Yj62f9xPNtCQd7rheLNdTorDo5G6Jz2SdcQvxwQeebig3Jwo_XUyFm-fD4ie_Fm_49xsKxK3nVzzmSen9U_Zo0FOkZ6f3nH27vPi6_VRcf_54tf1wXZgGMRV1RQDaNn2NbU-DlZ0WxiI2lW5rsEI0QmCPpGUrOqsRWmMt7TQMOxhqlNU5e3mcuw_-94FiUqM_5PWnqLCBus8OUWWVOKpM8DEGGtQ-uDlfrBDUClONaoWpVpgKUGWY2fTiNPqwyyDuLSd6WfDqJNDR6GkIejEu_tUJRNF2fZN1b486yiBuHQUVjaPFZLiBTFLWu__v8e4fu5nc4vKPv-iO4v29KgoF6ssa-5o6yJw41LL6AyjHprM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504810623</pqid></control><display><type>article</type><title>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Engler, Renata J.M., MD, FAAAAI, FACAAI ; With, Catherine M., JD, LLM, LLM ; Gregory, Philip J., PharmD ; Jellin, Jeff M., PharmD</creator><creatorcontrib>Engler, Renata J.M., MD, FAAAAI, FACAAI ; With, Catherine M., JD, LLM, LLM ; Gregory, Philip J., PharmD ; Jellin, Jeff M., PharmD</creatorcontrib><description>Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2009.01.001</identifier><identifier>PMID: 19203654</identifier><identifier>CODEN: JACIBY</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>adverse reactions ; Allergy and Immunology ; Alternative medicine ; Bias ; Biological and medical sciences ; Biological Products - adverse effects ; Biological Products - therapeutic use ; Clinical trials ; Complementary and alternative medicine ; Complementary Therapies - adverse effects ; Complementary Therapies - ethics ; Complementary Therapies - legislation &amp; jurisprudence ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Health Personnel - ethics ; Health Services Needs and Demand - ethics ; Health Services Needs and Demand - legislation &amp; jurisprudence ; Herb-Drug Interactions ; herbals ; herbs ; Humans ; Hypersensitivity - immunology ; Hypersensitivity - therapy ; integrative medicine ; Medical sciences ; Meetings ; Patients ; Physicians ; Plant Preparations - adverse effects ; Plant Preparations - therapeutic use ; Plants, Medicinal ; quality of care ; Quality of life ; Ratings &amp; rankings ; risk communication ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Studies ; Treatment Outcome ; Validity</subject><ispartof>Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.309-316.e4</ispartof><rights>American Academy of Allergy, Asthma &amp; Immunology</rights><rights>2009 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited Feb 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</citedby><cites>FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2009.01.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21126785$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19203654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Engler, Renata J.M., MD, FAAAAI, FACAAI</creatorcontrib><creatorcontrib>With, Catherine M., JD, LLM, LLM</creatorcontrib><creatorcontrib>Gregory, Philip J., PharmD</creatorcontrib><creatorcontrib>Jellin, Jeff M., PharmD</creatorcontrib><title>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.</description><subject>adverse reactions</subject><subject>Allergy and Immunology</subject><subject>Alternative medicine</subject><subject>Bias</subject><subject>Biological and medical sciences</subject><subject>Biological Products - adverse effects</subject><subject>Biological Products - therapeutic use</subject><subject>Clinical trials</subject><subject>Complementary and alternative medicine</subject><subject>Complementary Therapies - adverse effects</subject><subject>Complementary Therapies - ethics</subject><subject>Complementary Therapies - legislation &amp; jurisprudence</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Health Personnel - ethics</subject><subject>Health Services Needs and Demand - ethics</subject><subject>Health Services Needs and Demand - legislation &amp; jurisprudence</subject><subject>Herb-Drug Interactions</subject><subject>herbals</subject><subject>herbs</subject><subject>Humans</subject><subject>Hypersensitivity - immunology</subject><subject>Hypersensitivity - therapy</subject><subject>integrative medicine</subject><subject>Medical sciences</subject><subject>Meetings</subject><subject>Patients</subject><subject>Physicians</subject><subject>Plant Preparations - adverse effects</subject><subject>Plant Preparations - therapeutic use</subject><subject>Plants, Medicinal</subject><subject>quality of care</subject><subject>Quality of life</subject><subject>Ratings &amp; rankings</subject><subject>risk communication</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Studies</subject><subject>Treatment Outcome</subject><subject>Validity</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-LFDEQxYMo7rj6BTxIQDx2W5X-GxFFhl1dWPCgoreQSardtN2dMcks7Lc3zQwuePAUinqvUvV7jD1HKBGwfT2WozauFACyBCwB8AHbIMiuaHvRPGSb3MCi7Wp5xp7EOEKuq14-ZmcoBVRtU2_Yj62f9xPNtCQd7rheLNdTorDo5G6Jz2SdcQvxwQeebig3Jwo_XUyFm-fD4ie_Fm_49xsKxK3nVzzmSen9U_Zo0FOkZ6f3nH27vPi6_VRcf_54tf1wXZgGMRV1RQDaNn2NbU-DlZ0WxiI2lW5rsEI0QmCPpGUrOqsRWmMt7TQMOxhqlNU5e3mcuw_-94FiUqM_5PWnqLCBus8OUWWVOKpM8DEGGtQ-uDlfrBDUClONaoWpVpgKUGWY2fTiNPqwyyDuLSd6WfDqJNDR6GkIejEu_tUJRNF2fZN1b486yiBuHQUVjaPFZLiBTFLWu__v8e4fu5nc4vKPv-iO4v29KgoF6ssa-5o6yJw41LL6AyjHprM</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Engler, Renata J.M., MD, FAAAAI, FACAAI</creator><creator>With, Catherine M., JD, LLM, LLM</creator><creator>Gregory, Philip J., PharmD</creator><creator>Jellin, Jeff M., PharmD</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20090201</creationdate><title>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</title><author>Engler, Renata J.M., MD, FAAAAI, FACAAI ; With, Catherine M., JD, LLM, LLM ; Gregory, Philip J., PharmD ; Jellin, Jeff M., PharmD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>adverse reactions</topic><topic>Allergy and Immunology</topic><topic>Alternative medicine</topic><topic>Bias</topic><topic>Biological and medical sciences</topic><topic>Biological Products - adverse effects</topic><topic>Biological Products - therapeutic use</topic><topic>Clinical trials</topic><topic>Complementary and alternative medicine</topic><topic>Complementary Therapies - adverse effects</topic><topic>Complementary Therapies - ethics</topic><topic>Complementary Therapies - legislation &amp; jurisprudence</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Health Personnel - ethics</topic><topic>Health Services Needs and Demand - ethics</topic><topic>Health Services Needs and Demand - legislation &amp; jurisprudence</topic><topic>Herb-Drug Interactions</topic><topic>herbals</topic><topic>herbs</topic><topic>Humans</topic><topic>Hypersensitivity - immunology</topic><topic>Hypersensitivity - therapy</topic><topic>integrative medicine</topic><topic>Medical sciences</topic><topic>Meetings</topic><topic>Patients</topic><topic>Physicians</topic><topic>Plant Preparations - adverse effects</topic><topic>Plant Preparations - therapeutic use</topic><topic>Plants, Medicinal</topic><topic>quality of care</topic><topic>Quality of life</topic><topic>Ratings &amp; rankings</topic><topic>risk communication</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Studies</topic><topic>Treatment Outcome</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Engler, Renata J.M., MD, FAAAAI, FACAAI</creatorcontrib><creatorcontrib>With, Catherine M., JD, LLM, LLM</creatorcontrib><creatorcontrib>Gregory, Philip J., PharmD</creatorcontrib><creatorcontrib>Jellin, Jeff M., PharmD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Engler, Renata J.M., MD, FAAAAI, FACAAI</au><au>With, Catherine M., JD, LLM, LLM</au><au>Gregory, Philip J., PharmD</au><au>Jellin, Jeff M., PharmD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>123</volume><issue>2</issue><spage>309</spage><epage>316.e4</epage><pages>309-316.e4</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><coden>JACIBY</coden><abstract>Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19203654</pmid><doi>10.1016/j.jaci.2009.01.001</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.309-316.e4
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_1504810623
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects adverse reactions
Allergy and Immunology
Alternative medicine
Bias
Biological and medical sciences
Biological Products - adverse effects
Biological Products - therapeutic use
Clinical trials
Complementary and alternative medicine
Complementary Therapies - adverse effects
Complementary Therapies - ethics
Complementary Therapies - legislation & jurisprudence
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Health Personnel - ethics
Health Services Needs and Demand - ethics
Health Services Needs and Demand - legislation & jurisprudence
Herb-Drug Interactions
herbals
herbs
Humans
Hypersensitivity - immunology
Hypersensitivity - therapy
integrative medicine
Medical sciences
Meetings
Patients
Physicians
Plant Preparations - adverse effects
Plant Preparations - therapeutic use
Plants, Medicinal
quality of care
Quality of life
Ratings & rankings
risk communication
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Studies
Treatment Outcome
Validity
title Complementary and alternative medicine for the allergist-immunologist: Where do I start?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T12%3A35%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complementary%20and%20alternative%20medicine%20for%20the%20allergist-immunologist:%20Where%20do%20I%20start?&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Engler,%20Renata%20J.M.,%20MD,%20FAAAAI,%20FACAAI&rft.date=2009-02-01&rft.volume=123&rft.issue=2&rft.spage=309&rft.epage=316.e4&rft.pages=309-316.e4&rft.issn=0091-6749&rft.eissn=1097-6825&rft.coden=JACIBY&rft_id=info:doi/10.1016/j.jaci.2009.01.001&rft_dat=%3Cproquest_cross%3E3239287941%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504810623&rft_id=info:pmid/19203654&rft_els_id=1_s2_0_S0091674909000049&rfr_iscdi=true